Idarubicin Injection 5 mg/5 mL (4)

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

idarubicin hydrochloride, Quantity: 1 mg/mL

Disponible desde:

Pfizer (Perth) Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Vía de administración:

Intravenous Infusion, Intravenous

Unidades en paquete:

1 X 5 mL

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

TAIWAN Acute non-lymphatic leukaemia (ANLL) in adults. Acute lymphatic leukaemia (ALL) in adults and children

Resumen del producto:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Listed (Export Only)

Fecha de autorización:

2023-03-20